19 April 2022 | News
Comera will develop a differentiated formulation of an Intas product
Image credit: Shutterstock
Ahmedabad-based Intas Pharmaceuticals has announced a research collaboration with US-based Comera Life Sciences, to develop a new generation of bio-innovative biologic medicines to improve patient access, safety, and convenience.
Under the terms of the partnership agreement, Comera will develop a differentiated formulation of an Intas product using Comera's innovative proprietary SQore formulation platform.
Intas will initially provide research funding with the option to acquire global rights to the formulation through an exclusive license with responsibility for subsequent development and commercialisation.
Binish Chudgar, Vice Chairman and Managing Director of Intas Pharmaceuticals said, "This collaboration will accelerate our quest to develop innovative, value-added medicines that can make a difference in patients' lives globally."